Balrampur Chini to raise ₹650cr; PLA capex up in 2026

What the board approved and why it matters

Balrampur Chini Mills Ltd has cleared a set of financing and project decisions that expand its diversification plans in Uttar Pradesh. The company said it will invest up to ₹160 crore to set up a lactogypsum processing plant at Kumbhi. It also approved raising up to ₹450 crore through a preferential issue of equity shares. Alongside the equity raise, the board approved raising up to ₹200 crore through non-convertible debentures (NCDs) on a private placement basis.

The company also increased the estimated capital outlay for its upcoming poly lactic acid (PLA) manufacturing plant in UP. The revised project cost is now ₹3,080 crore, higher than the earlier estimate of ₹2,850 crore. These approvals collectively show how the company plans to fund new verticals beyond sugar, ethanol and power.

Board meeting timeline and disclosures

Balrampur Chini disclosed the decisions through a regulatory filing. The board meeting to consider the proposals commenced at 11:00 AM and concluded at 2:45 PM on April 23, 2026. The company outlined both the project approvals and the proposed funding mix.

The filing also tied the lactogypsum plant to the PLA project, positioning it as a byproduct-utilisation unit. The financing plan includes equity via preferential allotment, debt through NCDs, and internal accruals for parts of the overall project pipeline.

Lactogypsum plant at Kumbhi: cost, capacity, purpose

The board approved establishing a lactogypsum processing plant at Kumbhi, Uttar Pradesh, with an estimated project cost of up to ₹160 crore. The proposed facility will have an installed capacity of about 76 lakh gypsum boards per annum. The stated purpose is to process lactogypsum generated as a byproduct from the company’s PLA manufacturing operations.

Balrampur Chini also approved utilisation of a portion of the net proceeds from the preferential issue towards this project. The company said up to ₹160 crore of the preferential issue proceeds may be used for funding the lactogypsum plant.

PLA project: capex revised to ₹3,080 crore

The company revised upwards the estimated capital outlay for its 80,000 tonnes per annum PLA project from ₹2,850 crore to ₹3,080 crore. The board said the revision is due to cost escalations of about ₹230 crore. It cited three drivers: increases in prices of key construction materials, global supply chain disruptions, and changes in engineering and designing incorporated during the modelling review.

Balrampur Chini said the revised enhanced capex, including cost escalations, will be funded through a combination of a preferential issue, debt and internal accruals. The project is being set up at Kumbhi in Uttar Pradesh and is part of the company’s diversification into bio-plastics.

Preferential issue: ₹450 crore, ₹483 per share

Balrampur Chini’s board approved issuance and allotment of up to 93,16,771 equity shares for cash at ₹483 per share. The total amount to be raised aggregates up to ₹450 crore. The company said the allotment is to promoters, members of the promoter group, and investors on a preferential basis.

A portion of the proceeds, up to ₹160 crore, is earmarked for the lactogypsum processing plant. The broader equity infusion is also part of the funding plan for the revised PLA capex, alongside debt and internal accruals.

NCD plan: up to ₹200 crore via private placement

In addition to the equity raise, the board approved raising up to ₹200 crore through issuance of non-convertible debentures on a private placement basis. The company said the NCDs may be issued in one or more tranches. It also indicated that specific terms such as tenure, coupon rate and security details will be disclosed at the time of each allotment.

This adds a debt component to the capital structure for the planned capex pipeline, complementing the preferential equity issuance and internal funding.

Operating base: sugar, distillery and co-generation scale

Balrampur Chini is one of the largest integrated sugar companies in India. It has ten sugar factories in Uttar Pradesh with an aggregate sugarcane crushing capacity of 80,000 tonnes per day. The company also operates distillery and co-generation assets.

It has distillery operations of 1,050 kilo litre per day and co-generation capacity of 175.7 MW. The company is headquartered in Kolkata and has been expanding beyond the core sugar business into newer segments such as bio-plastics.

How the byproduct strategy fits the PLA vertical

The lactogypsum plant is positioned as a downstream unit linked to the PLA project’s operating output. The company said lactogypsum will be generated as a byproduct from its PLA manufacturing operations and the proposed unit is intended to process it.

The capacity is expressed in gypsum boards per annum, suggesting a focus on converting byproduct into saleable building-material output. The linkage between the two projects also explains why the company intends to use a portion of the preferential issue proceeds for the lactogypsum facility.

Key facts snapshot

Market impact: what investors will track from here

The immediate market relevance is the combined funding plan and the revised project cost for a large capex programme. The company has clearly stated that the enhanced PLA capex will be funded through a mix of preferential equity, debt and internal accruals. Investors typically track how quickly such funding is tied to execution milestones and whether additional cost escalation is required later.

The lactogypsum plant approval adds another capex item but also signals an attempt to monetise a byproduct stream from the PLA vertical. The NCD approval expands the company’s financing options, although the company has not disclosed the instrument terms yet.

Conclusion

Balrampur Chini has approved a ₹450 crore preferential equity issue, an NCD raise of up to ₹200 crore, and a new ₹160 crore lactogypsum processing plant at Kumbhi in Uttar Pradesh. At the same time, it raised the estimated capex for its 80,000 TPA PLA project to ₹3,080 crore, citing material costs, supply chain disruptions and design changes. The next set of updates is likely to centre on fundraising execution, disclosure of NCD terms at the time of allotments, and progress on the Kumbhi project pipeline.